Alkermes Plc (ALKS.O) Insider Trading | Reuters.com
Edition:
United States

Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

43.53USD
12:19pm EDT
Change (% chg)

$0.93 (+2.18%)
Prev Close
$42.60
Open
$43.55
Day's High
$43.76
Day's Low
$42.66
Volume
345,513
Avg. Vol
1,327,012
52-wk High
$80.71
52-wk Low
$27.14

BREYER ROBERT A

Institutional Holders

% Shares Owned: 98.66%
# of Holders: 364
Total Shares Held: 149,133,868
3 Mo. Net Change: 4,000,914
# New Positions: 34
# Closed Positions: 92
# Increased Positions: 152
# Reduced Positions: 208
# Net Buyers: -56

Officers & Directors

Name Age Since Current Position

Richard Pops

52 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

52 2011 President

James Frates

47 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

57 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

56 2016 Executive Vice President, Chief Administrative Officer, Chief Compliance Officer, Secretary

Elliot Ehrich

55 2015 Executive Vice President, Research and Development and Chief Medical Officer

Rebecca Peterson

39 Senior Vice President - Corporate Communications

Michael Landine

61 2011 Senior Vice President - Corporate Development

Mark Stejbach

51 2012 Senior Vice President, Chief Commercial Officer

Iain Brown

46 2015 Chief Accounting Officer

Paul Mitchell

62 2012 Lead Independent Director

Nancy Snyderman

57 2016 Director

Nancy Wysenski

57 2013 Director

David Anstice

66 2011 Independent Director

Floyd Bloom

78 2011 Independent Director

Robert Breyer

71 2011 Independent Director

Wendy Dixon

60 2011 Independent Director